Franz Gabor
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Glycosylation and Glycoproteins Research 16
-
- Advanced Drug Delivery Systems 20
- Co-authors
- Michael Wirth (75 shared papers)Lukas Neutsch (12 shared papers)Eva Untersmayr (7 shared papers)Erika Jensen‐Jarolim (6 shared papers)Fritz Pittner (9 shared papers)Christoph Arnoldner (14 shared papers)Clemens Honeder (13 shared papers)Juan M. Irache (2 shared papers)
- Journals
- Journal of Controlled Release (10 papers)International Journal of Pharmaceutics (10 papers)European Journal of Pharmaceutics and Biopharmaceutics (9 papers)Pharmaceutical Research (5 papers)Acta Biomaterialia (4 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Franz Gabor
116 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 125
- Pharmaceutical Science 730
- Biomaterials 554
- Sensory Systems 128
- Immunology and Allergy 136
- Neurology 189
Countries citing papers authored by Franz Gabor
This map shows the geographic impact of Franz Gabor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franz Gabor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franz Gabor more than expected).
Fields of papers citing papers by Franz Gabor
This network shows the impact of papers produced by Franz Gabor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franz Gabor. The network helps show where Franz Gabor may publish in the future.
Co-authors
The 25 scholars most cited alongside Franz Gabor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 201 | |
| 2 | 2002 | 111 | |
| 3 | 1999 | 103 | |
| 4 | 1999 | 82 | |
| 5 | 2004 | 81 | |
| 6 | 2006 | 81 | |
| 7 | 2010 | 76 | |
| 8 | 2004 | 73 | |
| 9 | 1998 | 72 | |
| 10 | 1998 | 68 | |
| 11 | 2003 | 67 | |
| 12 | 2002 | 66 | |
| 13 | 1999 | 64 | |
| 14 | 2007 | 58 | |
| 15 | 2004 | 51 | |
| 16 | 2004 | 50 | |
| 17 | 2000 | 49 | |
| 18 | 2011 | 48 | |
| 19 | 2008 | 47 | |
| 20 | 1997 | 46 |
About Franz Gabor
Franz Gabor is a scholar working on Molecular Biology, Pharmaceutical Science, Biomedical Engineering, Biomaterials and Surgery, having authored 116 papers that have together received 3.0k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (20 papers), Glycosylation and Glycoproteins Research (16 papers), Nanoparticle-Based Drug Delivery (11 papers), Microfluidic and Bio-sensing Technologies (9 papers), Hearing, Cochlea, Tinnitus, Genetics (9 papers), Bladder and Urothelial Cancer Treatments (9 papers), Urinary Tract Infections Management (7 papers) and Transgenic Plants and Applications (7 papers). The work is most often cited by research in Pharmaceutical Science (730 citations), Biomaterials (554 citations), Sensory Systems (128 citations), Immunology and Allergy (136 citations) and Neurology (189 citations). Franz Gabor has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Michael Wirth, Lukas Neutsch, Eva Untersmayr, Erika Jensen‐Jarolim, Fritz Pittner, Christoph Arnoldner, Clemens Honeder, Juan M. Irache, Otto Scheiner and Helmut Viernstein. Their work appears in journals such as Journal of Controlled Release, International Journal of Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics, Pharmaceutical Research and Acta Biomaterialia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.